14 November 2020 04:34
In the past nine months, my administration has initiated the single greatest mobilization in U.S. history — pioneering, developing, and manufacturing therapies and vaccines in record time. As a result of Operation Warp Speed, Pfizer announced on Monday that its China virus vaccine is more than 90 percent effective. As soon as April, the vaccine will be available to the entire general population, with the exception of places like New York state, where, for political reasons, the governor decided, they say — and, you know, I don't think it's good, politically; I think it's very bad from a health standpoint — but he wants to take his time with the vaccine. It's incredible, some of the antibody vaccines and others that have come out and have really helped people — 85 percent. The federal government has 22,000 beds immediately available for states and jurisdictions that need additional capacity, but we think that it's going to start going down, possibly very quickly.
So Operation Warp Speed's mission is to enable and accelerate the development of vaccines and therapeutics to help control the COVID-19 pandemic and save lives. On May 15th, almost six months ago to the day, we stated the goal of the operation, which was to have vaccines and therapeutics available and approved for use in the U.S. population by the end of the year 2020. I would like to take this opportunity to invite as many Americans as possible who would like to volunteer to participate in these clinical trials, as that's the only way we are able to achieve a demonstration of the safety and the efficacy of these vaccines. So the two vaccines that are completing their phase three trial are likely to be filing their files with the FDA for a potential emergency use authorization within the next few weeks. And finally, AstraZeneca, just in the last few days, has received a green light to start two large phase three trials with their monoclonal antibodies, supported by Operation Warp Speed, to prevent the acquisition of COVID-19 disease in very frail subjects or in very high-risk subjects, as a protective alternative to a vaccine.
The President said, "That's not acceptable." And thanks to the support he's provided, we're now on track to deliver a safe and effective vaccine to our most vulnerable this year. The President gave us the full financial support we needed, enabling us to invest more than $10 billion to de-risk vaccine companies' development efforts and manufacture product in advance. Our completely unprecedented partnership with the Defense Department has given us a comprehensive public-private plan for distribution and help each Operation Warp Speed vaccine maker secure what they needed for manufacturing, including Pfizer's ongoing production this week. Because the President has delivered the full funding we need, the best people on the planet, and real independence for this project, Operation Warp Speed is doing something that has never been done before in history. It was your vision that we could harness the ingenuity and the creativity of America's greatest pharmaceutical and research companies to speed, in record time, a vaccine that would save American lives.
In his first public comments since the week of the U.S. election, Trump will update on the U.S. government program that has struck deals with several drugmakers in an effort to help speed up the search for effective treatments for the ongoing global coronavirus pandemic. Watch live coverage as President Trump gives an update on Operation Warp Speed and his administration's coronavirus response. President Trump said on Friday that pharmaceutical giant Pfizer offered an "unfortunate misrepresentation" when the company distanced itself from Operation Warp Speed. "We were never part of the Warp Speed," Kathrin Jansen, senior vice president and head of vaccine research and development at Pfizer, told the New York Times on Sunday. Earlier this week, Pfizer and BioNTech said clinical data showed their COVID-19 vaccine candidate to be 90% effective and that they could file for emergency use authorization with U.S. Food and Drug Administration by the third week of November. In July, Pfizer struck a $1.95 billion deal with the federal government as part of Operation Warp Speed, in an effort to deliver 100 million doses of the vaccine. President Donald Trump to make remarks on Operation Warp Speed Public health experts worry that Trump's refusal to take aggressive action on the pandemic or to coordinate with the Biden team during the final two months of his presidency will only worsen the effects of the virus and hinder the nation's ability to swiftly distribute a vaccine next year. With more than 100,000 new confirmed U.S. cases reported daily for more than a week, Trump has been more focused on tracking the rollout of a vaccine, which won't be widely available for months. Although the president has consistently played down the pandemic, which has killed more than 240,000 Americans and infected more than 10 million people in the U.S., public health experts expressed worry about Trump's silence on the troubling spike in cases, as well as his refusal to begin coordination on virus issues with Biden's transition team. Some public health experts believe the task of persuading Americans to take the vaccine and widely distributing it could be as complicated as the vaccine's development.